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Abstract:  
C-terminal binding proteins 1 and 2 (CtBP1 and CtBP2) are transcriptional regulators that 
activate or repress many genes involved in cellular development, apoptosis and 
metastasis.  CtBP proteins are activated under hypoxic conditions where NAD(H) levels 
tend to be higher. NADH-dependent activation of CtBP2 has direct implication in 
multiple types of cancers and poor patient prognosis. Previous studies have proposed 
dimeric CtBP as the relevant oligomeric state, however our studies with multi-angle light 
scattering have shown that the primary effect of NADH binding is to promote the 
assembly of two CtBP dimers into tetramers. Here, we present the cryoEM structures of 
two different constructs of CtBP2 corroborating that the native state of CtBP2 in the 
presence of NADH is indeed tetrameric. The physiological relevance of tetrameric CtBP2 
was tested in HCT116; CtBP2 -/- cells transfected with tetramer destabilizing mutants. 
Mutants that inhibit tetramer formation show a decrease in expression of the CtBP 
transcriptional target TIAM1 and exhibit a decrease in the ability to promote cell 
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migration. Together with our cryoEM studies, these results highlight the tetramer as the 
functional oligomeric form of CtBP2.   
Keywords: C-terminal Binding-Proteins (CtBPs), Transcription regulation, Cancer, 
TIAM1. Metastasis 
   
Introduction: 
C-terminal Binding proteins 1 and 2 (CtBP1 and CtBP2) are co-transcriptional 
factors that regulate important genes in cell fate. CtBP1 was first identified as an 
interacting partner of the Adenovirus 2/5 E1A protein (Boyd et al., 1993); binding 
occurred at the C-terminal region of E1A, resulting in the name of CtBP. CtBPs can act as 
both activators and repressors of transcription through their interactions with multiple 
transcription factors and chromatin modifier enzymes (Kuppuswamy et al., 2008). 
Although CtBP1 and CtBP2 share over 80% amino acid sequence identity, their functions 
are both unique and redundantly overlapping within the cell (Hildebrand & Soriano, 
2002) (Chinnadurai, 2007). Unlike CtBP1, CtBP2 has a nuclear localization signal (NLS) 
at its N-terminus domain suggesting a more critical role for the latter in transcription 
(Hildebrand & Soriano, 2002; Ma et al., 2020). The transcriptional activity of CtBPs can 
confer resistance to apoptosis and promote metastasis and oncogenesis depending on 
their interacting partners (Chinnadurai, 2009). CtBPs may be activated under conditions 
of hypoxia where the NADH level is elevated in the cell, which has direct implication in 
various forms of cancer (Di et al., 2013). CtBP expression has been observed to be higher 
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in colorectal cancer, melanoma, metastatic prostate cancer, ovarian cancer and breast 
cancer (Barroilhet et al., 2013; Deng et al., 2013; Wang et al., 2012). CtBPs promote 
tumorigenesis by enhancing epithelial-mesenchymal transition (EMT) and conferring 
resistance to apoptosis by regulating the expression of genes such as TIAM1 and Bik, 
respectively (Grooteclaes et al., 2003) (Ma et al., 2020; Paliwal et al., 2012). 
Furthermore, elevated levels of CtBP in tumor tissue are correlated with poorer survival 
in breast cancer, ovarian cancer and hepatocellular carcinoma (Zheng et al., 2015; 
Chawla et al., 2019). The substantial data correlating CtBP with cancer progression 
implicates CtBP as a potential drug target. 
Oligomerization is essential for CtBP transcriptional activity, with CtBP forming 
dimers (Kumar et al., 2002; Nardini et al., 2003) and higher order structures (Bellesis et 
al., 2018; Madison et al., 2013). Binding of NAD(H) promotes oligomerization of CtBP2, 
which is required for transcriptional activities (Kumar et al., 2002; Zhang et al., 2002). In 
conditions where the level of NAD(H) is low, CtBP2 is mostly dimeric (Bellesis et al., 
2018). Increasing the level of NADH in the cell promotes oligomerization of CtBP2. The 
activated oligomeric form of CtBP can then associate with other transcriptional co-
activators and enzymes to form the CtBP-mediated repression complex (Shi et al., 2003). 
Although previous studies have proposed dimeric CtBP as the relevant oligomeric state 
(Nardini et al., 2003; Thio et al., 2004;  Nardini et al., 2009; Bi et al., 2018; Mani-Telang 
et al., 2007;  Dcona et al., 2019), our studies with multi-angle light scattering and site-
directed mutagenesis have shown that the primary effect of NADH binding is to promote 
the assembly of two CtBP dimers into tetramers (Bellesis et al., 2018). This was further 
.CC-BY-NC-ND 4.0 International licenseauthor/funder. It is made available under a
The copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.04.06.027573doi: bioRxiv preprint 
supported by the observation that CtBP1 and CtBP2 exhibit similar tetrameric assemblies 
within distinct crystal lattices used for structure determination (Hilbert et al., 2014), 
resulting in a tetramer model for CtBP. 
The goal of the present study is to determine the structure of CtBP2 in solution. 
Solving the structure without the influence of a crystalline lattice will permit us to 
investigate the importance of the tetrameric assemblage for transcriptional activity in 
cellular function. We have determined the solution structures of CtBP2 by cryoEM at an 
average resolution of 3.6Å, for the minimal dehydrogenase domain, and a low resolution 
reconstruction of a construct with the full C-terminus, corroborating that the native 
oligomeric state of CtBP with bound NADH is tetrameric.  Moreover, mutagenesis of key 
residues involved in interdimer interface diminish the expression of TIAM1 and cell 
migration in HCT116; CtBP2(-/-) cells supporting a key role of the tetrameric assembly 
in co-transcriptional function of CtBP2.  Thus the tetrameric structure of CtBP2 in 
solution is validated as the functionally active form of the enzyme.  
Results:  
Overall Structure of the minimal dehydrogenase domain of CtBP2, CtBP31-364 
CtBP2, a 445 residue protein, has required truncations for crystallographic and cryoEM 
structure determination. The first 30 residues which contain part of the PXDLS motif 
(Bergman & Blaydes, 2006),  are removed from all of our constructs.  Crystallization 
required the removal of the C-terminal (82 residues), which has been shown to be 
disordered (Nardini et al., 2006). We pursued cryoEM structure determination of 
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CtBP231-445, with the full C-terminus, and CtBP31-364 truncation that is equivalent to the 
construct we crystalized (Hilbert et al., 2014). The CtBP231-364 construct yielded better 
data with less preferred orientation (Figures S1, S4) and thus is the focus of the detailed 
analysis. CtBP231-364 was expressed in E. coli cells and purified as reported previously 
(Hilbert et al., 2014; Hilbert et al., 2015). The cryoEM structure determination was 
performed using both C1 and D2 symmetry, with the D2 symmetry resulting in slightly 
higher resolution. Reference-free 2D classification reveals distinct classes with different 
views of the particles (Figure S1). The 2D classes also indicate high stability of the 
tetramer complex.  Moreover, reference-free 2D classification only shows classes of the 
tetramer with no dimeric classes (Figure S1). 3D refinement and classification in 
RELION led to a 3.9Å (FSC = 0.143 criterion) map (Figure 1), which improved with per 
particle CTF refinement to a final resolution of 3.6Å (Figures S3, S4A-B). Overall the 
final EM reconstruction reveals a tetramer of CtBP2 bound with four molecules of 
NADH (Figure 1C), whose subunit arrangement is very similar to that derived from the 
crystallographic analysis. Thus, the previously observed tetramer in X-ray 
crystallographic experiments was not due to crystal contacts, but to the fact that the 
native state of NADH bound CtBP2 is tetrameric.  
Overall Structure of CtBP2 with the flexible C-terminal tail, CtBP31-445 
To tease out the role that the last 80 amino acids of CtBP2 play in tetramer assembly and 
stability we determined the cryoEM structure of CtBP231-445  (Figures 2 & S3). Despite 
collecting the data under identical conditions as the truncated construct, the longer 
construct yielded poor quality maps that appear to result from preferred orientation on the 
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EM grids (Figure S3D) (Tan et al., 2017).  The data was first analyzed without any 
imposed symmetry hoping to visualize the last 82 amino acids, which are predicted to be 
highly flexible. Although some 2D and 3D classes showed extra density, this density 
could not confidently be assigned to the C-terminal flexible tail (Figure S3C, S4). 
Overall, the CtBP231-445 reconstruction performed with D2 symmetry shows tetramers 
similar to the truncated construct. The first observation made by comparing the 2D 
classes between CtBP31-364 and CtBP31-445 was that the former had more side views 
(Figures S1, S3B).  Consequently, the EM map for CtBP31-445 is limited by preferred 
orientation of particles (Figure S3D).  The number of particles in the final reconstruction 
together with the orientation bias gave rise to a reconstruction with an average resolution 
of 6Å-12Å.  The low quality reconstruction in the presence of the flexible C-terminal 
domain is likely attributed to a propensity to orient in the EM grids in a small number of 
preferred orientations.   
Comparison of CtBP231-364 to CtBP231-445:  
To analyze how CtBP231-445 might deviate from the truncated construct a low-pass filtered 
map of CtBP231-364 (Figures 2B & S5) was generated. Difference maps analysis reveals 
that the monomers in the longer construct are rotated at an angle to bring the NADH 
biding pocket of each monomer closer together (Figure 2B). This observation supports 
the finding that FL-CtBP proteins formed more stable tetramers as compared to a 
truncated construct (Madison et al., 2013).  Since this cannot be quantified, we 
hypothesize that rotation of one chain toward the adjacent one would result in a tighter 
interface, thus a stronger interaction between the two chains. Contrary to previous reports 
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that the last 82 amino acids are required for CtBP2 to assemble into a stable tetramer 
(Madison et al., 2013) we unambiguously demonstrate that CtBP231-364 forms a tetrameric 
structure similar to CtBP231-445  (Figures 1A & 2A).  
Tetrameric Model of  CtBP231-364 
The final cryoEM map of CtBP231-364 provided very clear secondary structural features 
(Figure S6) that permitted rigid-body fitting of the tetrameric crystallographic structure 
(Hilbert et al., 2014) in Chimera (Pettersen et al., 2004). This fitting was followed by 
multiple rounds of resulting in a model with high real-space correlation and optimized 
stereochemical fit (Table 1) (Figure 3). Pairwise superposition of the two structures 
yields an average RMSD of 0.8 Å. Cα-Cα distance map analysis (Figures 3B & S7) 
reveals minor differences between the cryo-EM and crystallographic models mainly in 
loop regions, and interestingly a small rotation in the substrate domain relative to the 
larger coenzyme domain. Likely due to the stability of the NADH bound complex, 
comparisons of the two structures reveal that globally these complexes are very similar. 
Interactions stabilizing CtBP2 tetramer:  
Most of the structure of CtBP2 was well resolved with the high local resolution of the 
data set. Density for nearly all the side chains and NADH are clearly visible (Figure S6). 
Each CtBP monomer is composed of a substrate binding domain (31-126, 333-361) and a 
coenzyme-binding domain (131-325). The overall tetramer with D2 symmetry structure is 
formed by a dimer of dimers (Figures 4 & 5). The most extensive interactions occur at 
the dimer interface as we reported earlier (Bellesis et al., 2018) and shown here by the 
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PISA analysis in Table 2 of the cryoEM structure (Figure 5A & B). Each intradimer 
(AB and CD) buries approximately 3000Å2, compared to the 800Å2 surface area buried 
by the interdimers (AD, BC). Based on assembly pathway analyses done on homo-
tetramers, the first complex to assemble is the one with the largest buried surface (J. 
Chen, Sawyer, & Regan, 2013; Villar et al., 2009) (Quintyn, Yan, & Wysocki, 2015). 
Consequently, the assembly pathway for NADH-bound CtBP2 is a dimer to a tetramer.  
The tetramer interface in the electron density map could be well resolved and side chains 
placed to explain the tetramerization stability (Figures 4 & S6). The tetramer is stabilized 
by a set of residues clustered near the binding pocket of NADH (Arg190, Leu221), the 
hinge domains (Figure 4D) (Ser128, Ala129) and the hydrophobic clustering of Leu221 
at the interdimer interface. Some of these residues either directly contact NADH or 
interact with each other via a set of hydrogen bonding and hydrophobic interactions 
(Figure 4).  For instance, Arg190 participates both in hydrogen bonds with NADH, 
within its subunit, and the carbonyl oxygen of Asp215’, across the interdimer interface 
(Figures 4B & S6B).  Another set of interactions that stabilize the tetramer is the 
hydrophobic packing of the side chains of Leu221 (Figure 4C) located at the interdimer 
interface. Mutations of these residues that disrupt the tetrameric assembly (Bellesis et al., 
2018) provide an opportunity to investigate that role of tetramer stability and CtBP 
transcriptional activity.  
Tetramer Destabilizing Mutants Decrease Cell Migration:  
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Our cryoEM results establish that the tetrameric form of CtBP2 deduced from the 
crystal structure does represent the solution tetrameric structure and is not an artifact of 
the CtBP2 crystal lattice. Given the evidence correlating NADH binding and 
oligomerization with activation (Madison et al., 2013) (Bellesis et al., 2018), the stable 
tetrameric form of CtBP2 identified here is likely to be functionally important. To 
directly test the hypothesis that our observed tetrameric form is the functionally active 
form, plasmids encoding a series of CtBP2 mutants that have previously been shown to 
inhibit tetramer formation (Bellesis et al., 2018) were transfected into HCT116 colon 
cancer cells that have had CRISPR-mediated deletion of both CtBP2 alleles (Chawla et 
al., 2018). These transfected cell populations were then investigated for expression of the 
CtBP2 transcriptional target gene TIAM1 and induction of cell migratory activity, two 
cellular functions specifically correlated with oncogenic activity ( Dcona et al., 2017;  Ma 
et al., 2020).  
TIAM1 promotes cancer progression and metastasis, and CtBP2 is a key driver of 
TIAM1 transcription (Paliwal et al., 2012). To investigate the role of the CtBP2 
tetrameric assembly in transcriptional activation of TIAM1, plasmids encoding CtBP2WT, 
empty vector and tetramer destabilizing mutants (S128T, A129L, R190Q, G216N, 
L221Y) (Figure 4) were transfected into HCT116; CtBP2(-/-) cells. Monitoring of 
transfected cell lysates by CtBP2 immunoblot indicated equivalent expression of 
CtBP2WT and all five mutant proteins, as determined by densitometry of the CtBP2 and 
GAPDH loading control immunoblots (Figures S8 & S9). Following transfection, total 
RNA was extracted and TIAM1 mRNA abundance was determined by qPCR, as 
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described in the Experimental Procedures.  As shown in Figure 6A, transfection with 
pCtBP2WT resulted in more than a 2-fold increase of TIAM1 mRNA expression over the 
empty vector control. In sharp contrast, all five tetramer destabilizing mutants were 
defective for TIAM1 induction compared to CtBP2WT (p<0.01 for comparison of TIAM 
induction by CtBP2WT vs. each mutant). Indeed, each of the mutants appeared to repress 
TIAM1 transcription below basal levels seen with vector transfection, but the comparison 
of TIAM1 expression between vector and mutant CtBP2 transfection did not achieve 
statistical significance. Thus, CtBP2 mutants that are incapable of forming tetramers are 
also deficient in the transcriptional activation of TIAM1. 
Cellular migration is an important hallmark of oncogenesis and CtBP2 robustly 
induces cell migration and invasion in cell culture as a correlate of CtBP’s in vivo 
activities in promoting invasion and metastasis (Dcona et al., 2017). To test the 
contribution of the CtBP tetramer to the CtBP induction of cellular migration, a “scratch 
assay” was used in which HCT116; CtBP2(-/-) cells transfected with the vectors 
described above were grown to confluence and then a scratch was made on the plate, and 
cells were allowed to migrate into the scratched area, and closure of the scratch due to 
cell migration was quantified after 24 hours.  As shown in Figure 6B, closure of the 
scratch increased from a basal value of 40% with empty vector transfection to 
approximately 60% with the transfection of CtBP2WT expression vector. All five tetramer 
destabilizing mutants exhibited defective induction of migration compared to CtBP2WT 
(p<0.05). As for TIAM1 transcription, certain of the mutants appeared to exert a 
dominant negative effect, driving migration below basal levels, but these differences did 
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not achieve statistical significance. These results, thus, provide the first direct evidence 
that the tetrameric form of CtBP2, observed in the cryoEM reconstruction presented here, 
is required for co-transcriptional activity regulating TIAM1 expression and induction of 
cell migratory behavior. 
Discussion:  
 Eukaryotic gene transcription is regulated on many levels. One form of regulation 
involves recruitment of transcriptional factors and regulators that assemble into 
macromolecular complexes (Soutourina, 2018; Vilar & Saiz, 2005). Our structural 
analyses on CtBP231-364 and CtBP231-445 reveal a tetrameric assembly for the CtBP2 
protein. The observed tetramer is assembled from two dimers, each stabilized by both 
hydrophilic and hydrophobic interactions with an extensive interaction area of over 
3000Å2. In contrast, the tetramer formation is mediated by interacting loops from 
adjacent dimers with significantly lower interaction area, 800Å2. The model corroborates 
the previous crystallographic model that predicted the tetramer as the oligomeric state for 
both CtBP1 and CtBP2 (Bellesis et al., 2018). Our Cα-Cα distance analysis reinforces 
that the EM structure is very similar to the crystal model with no significant domain 
reorientation or movement due to the protein being in solution. As observed by Nardini et 
al, NADH binding locks t-CTBP/BARS into a closed conformation in which the substrate 
and co-enzyme binding domains are in close proximity (Nardini et al., 2003).  
 Previous studies suggested that although CtBP231-364   can form tetramers, the 
dimeric species would be more prevalent because the last eighty residues are missing. In 
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our cryoEM analysis, the only presented classes are tetrameric with no dimers observed. 
One major reason for that is the final concentration of the cryoEM sample will be higher 
compared to the concentration used for MALS and other biochemical assays, which will 
result in a higher binding between the subunits.  
 Despite the difference in resolution, the overall EM reconstruction for both CtBP2 
constructs was highly similar. The main difference lies in the orientation of the co-
enzyme binding domain of CtBP231-445, which has a slight rotation toward the adjacent 
chain. This rotation brings the two chains closer together and will consequently lead to 
tighter interactions. This result suggests that previous results showing greater tetramer 
formation in the presence of the C-terminal residues (Madison et al., 2013) may not result 
from specific intersubunit interactions involving the C-terminus, but rather from an effect 
of the disordered C-terminal domain altering domain orientation. 
 Our cryoEM studies not only confirm the tetrameric assembly, but also show that 
CtBP2 bound to NADH forms a stable complex. The latter is important because of 
CtBP’s role in promoting the assembly of higher order complexes such as the CtBP-
mediated repression complex (Turner & Crossley, 2001) (Good, Zalatan, & Lim, 2011; 
Sun & Fang, 2016).  As the hub for assembly of this complex, the tetramer stability and 
rigidity may be essential for the assembly of other co-factors.  Future studies of full-
length CtBP2 in complex with interacting partners may provide a detailed structural 
understanding of the role of the C-terminal domain both in tetramer stability and 
assembly of CtBP-mediated transcriptional complexes.  
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CtBP2 proteins have been shown to directly activate Tiam1 to facilitate EMT 
transition and cancer progression (Di et al., 2013; Paliwal et al., 2012). Our cell-based 
assay analysis of tetramer destabilizing CtBP2 mutants demonstrates that tetrameric 
assembly is required for transcriptional activity. As shown in Figure 6, tetramer-
destabilizing mutants abrogate induction of TIAM1 expression (Figure 6A), 
consequently affecting the ability of those mutants to induce cell migration (Figure 6B). 
The observation that tetramer-destabilizing mutants exhibit a possible dominant negative 
affect by lowering TIAM1 expression or cell migration below that seen with empty 
vector control is intriguing but the effect did not achieve statistical significance in our 
experiments. While beyond the scope of the present work, we speculate that such a 
dominant negative effect could result from CtBP2 forming dimers with endogenous 
CtBP1 that are then unable to assemble into tetramers. 
The co-transcriptional activators CtBP1 and CtBP2 have been extensively studied 
because of their implication in various cancers. High expression of CtBPs in cancerous 
cells is linked to poor outcomes (Bergman & Blaydes, 2006). Delineating the relevant 
assembly of these proteins in the cell is of critical importance for the development of 
targeted therapies that act through disruption of the CtBP tetramer.  
Experimental Procedures:  
Expression of CtBP231-364 and CtBP231-445 
The expression and purification procedures were adapted and optimized from 
earlier studies (Hilbert et al., 2014). The ligated, purified plasmid containing the 
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desired CtBP construct was transformed into Z-competent BL21(DE3) RIL E. coli 
cells. A single clonal colony was then grown in a starter culture of LB broth 
overnight at 37C. The starter culture was used to inoculate between three and six 
1L cultures grown in Research Products International Terrific Broth using 50mL 
starter per liter. Cultures were grown at 37C while shaking at 150RPM and 
induced with 1 mL 0.2 M IPTG after reaching OD600 between 0.800 and 1.00. The 
temperature was reduced to 30C at the time of induction and the cells were 
harvested four hours later. The cells were pelleted by centrifuging for 20 minutes 
at 4700 RPM, and resuspended in 10 mL harvesting buffer (pH 7.6; 0.1 M NaCl; 
0.05 M Tris-HCl; 0.2 mM EDTA) per liter of culture. One tablet of EDTA-free 
complete Mini (Roche Diagnostics) protease inhibitor cocktail was added per liter 
of culture.    
Purification of CtBP231-364 and CtBP231-445 
Cells were thawed slowly on ice and then lysed in a Microfluidics 
Corporation model 1109 cell disrupter. 35 mg of Roche Diagnostics DNase 
I, 500μL 2M MgCl2 and 500μL 40 mM CaCl2 were added per 100mL lysate. 
The lysate was then gently stirred at 4C for 30 minutes. The insoluble fraction 
was pelleted at 19,000RPM for 45 minutes. The supernatant was then mixed with 
8 mL HisPurTM Ni-NTA Resin (Thermo Scientific), and gently stirred at 4 for two 
hours to allow CtBP to bind to the resin.  
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The bead-supernatant mixture was placed in a BioRad Econo-Column® at 4C and 
the soluble fraction was allowed to flow through. The beads were then cleaned 
with 40 mL wash buffer (0.0625 M Tris:HCl pH 7.4; 0.375 M NaCl; 0.05 M 
imidazole; 0.625 mM EDTA; 1.0 mM DTT), followed by 50 mL of wash buffer 
supplemented with an additional 1.7 M NaCl. Another 10 mL wash buffer was 
passed over the beads before 50 mL wash buffer supplemented with 0.5% Triton-
X 100 was added. An additional 10 mL of wash buffer again followed. CtBP was 
eluted from the beads using 25 mL wash buffer supplemented with 250 mM 
imidazole. The protein was then concentrated by centrifuging at 5000 RPM in an 
Amicon® Ultra-15 10K centrifugation column (Millipore). Protein concentration 
was measured by UV absorbance at 280nm using an Ultraspec 2100 pro by 
Amersham Biosciences. The protein sample was further purified by FPLC. The 
FPLC (ÄTKAprime plus by GE Healthcare) and size exclusion column 
(Highload™ 16/60 Superdex™ 200 prep grade) were equilibrated with “FPLC 
Buffer” (50mM Tris:HCl pH 7.4, 300 mM NaCl, 5 mM EDTA, 2 mM DTT). The 
sample was prepared by adding 1.5 mM NADH to the concentrated protein 
solution 
The solution was then centrifuged at 8000RPM for six minutes at 4 to remove 
any small insoluble fraction. The flow rate was set to 1 mL/min and 62 fractions 
of 2 mL each were collected the appropriate fractions were concentrated in an 
Amicon® Ultra-15 10K centrifugation column. 
Sample preparation of CtBP231-364 and CtBP231-445 for CryoEM 
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For our cryoEM studies, two microliters of purified sample at a concentration of 
250nM CtBP231-364 and 500nM CtBP231-445 was added to glow-discharged, 200-
mesh C-flat 1.2/1.3 EM grids. The sample was blotted for 4s at 4°C under 95% 
humidity and vitrified in liquid ethane cooled by liquid nitrogen using the 
Vitroblot Mark IV.  
Image Acquisition 
The dataset for CtBP231-364 were recorded on the Talos Arctica operated at 200 kV 
equipped with a Gatan K3 summit direct electron detector operating in electron 
counting mode with -1.5 to -3μm defocus. Automated data acquisition was carried 
out using SerialEM (Mastronarde, 2005) at a nominal magnification of 57,000X 
with a pixel size of 0.435Å or CtBP231-364. In Total 3405 movies were recorded for 
CtBP231-364. 29 frames of movies were collected with a defocus range of -1.3 to 
-1.5 μm at a total dose of 37 electrons per Å2 
The images for CtBP231-445   were acquired on the Titan Krios (300kV) equipped 
with a Gatan K3 summit direct electron detector operating in electron counting 
mode with -1.5 to -3μm defocus. As above, automated data acquisition was 
carried out using SerialEM at a nominal magnification of 105,000X and a pixel 
size of 0.415Å, respectively. 4752 movies were collected for CtBP231-445 with a 
total of 25 frames at a total dose of 40 electrons per Å2 
Data Processing 
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Super-resolution movie frames were binned to the physical pixel of 0.87 and 0.83 
for CtBP231-364 and CtBP231-445, respectively. Alignment and beam-induced 
motion correction was done using IMOD (Kremer, Mastronarde, & McIntosh, 
1996). Contrast transfer function (CTF) parameters were estimated with 
CTFFIND4, reference-free particle picking was conducted in the cisTEM 
software package (Grant, Rohou, & Grigorieff, 2018; Grigorieff, 2016). For 
CtBP231-364 485,473 particles were selected from 3405 micrographs and extracted 
with a box of 256 pixels. The 671,078 particles of CtBP231-445 from 4752 
micrographs were extracted with a box of 300 pixels. For both datasets, reference-
free 2D classification with no imposed symmetry was carried out to attest the 
quality and homogeneity of the data. Three rounds of 2D classification were 
performed to further purify the CtBP231-445 data set.  
3D reconstruction of CtBP231-364 
Selected 2D classes were pooled to generate an Ab initio map in C1 in cisTEM. 
The particle stacks, CTF parameters and ab-inition models were transferred to 
RELION 3.0.2 for further processing (Zivanov et al., 2018). 3D classification 
yielded three classes (Sup. Fig. 3), the best class was extracted and further refined 
to higher resolution. All 3D classification and refinement were repeated in D2. A 
soft binary mask was generated and used for another round of 3D classification 
and refinement. Additionally we used per particle CTF estimation as implemented 
in RELION 3.0.2 to generate the 3.6Å map. B-factor determination was done 
automatically in RELION. Reported resolutions are based on the gold-standard 
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Fourier Shell Correlation (FSC) 0.143 criterion. Data processing and analysis for 
CtBP231-445 were performed similarly to the shorter construct. Due to the high 
noise level of the post-processed map, possibly due to over-masking, we tested 
different B-factor values to arrive at a decent reconstruction. The final 
reconstruction had an applied B-factor of -37Å2. Difference map analysis between 
C t B P 2 3 1 - 4 4 5 a n d C t B P 2 3 1 - 3 6 4 w a s d o n e u s i n g d i f f m a p ( h t t p : / /
grigoriefflab.janelia.org/diffmap) 
Model Building and Refinement  
Rigid body fitting was carried out in Chimera (Pettersen et al., 2004) by docking 
the CtBP2 tetramer model (PDB ID: 46UQ) into the map density. As a starting 
model we used the crystallographic tetramer for refinement. First round of 
refinement and model building were done in COOT (V0.8.9.2) (Emsley & 
Cowtan, 2004) . The model was further refined using Phenix.real_space_refine 
and stereochemistry was validated using phenix.molprobity (Table 1) (Adams et 
al., 2010) (V. B. Chen et al., 2010). Figures were generated in pymol and chimera. 
Resmap was used for local resolution estimation (Kucukelbir, Sigworth, & 
Tagare, 2014). To further parse out differences between the two models, we 
performed distance map analysis by comparing Cα-Cα distance between every 
pair of amino acids of the EM and crystal structures using Chimera RRdistMaps 
(J. E. Chen, Huang, & Ferrin, 2015). Interface and assembly analyses were 
calculated by PISA analysis (Krissinel & Henrick, 2007). The EM model was 
uploaded and analyzed on the PDBe PISA (v1.52) analysis software.  
.CC-BY-NC-ND 4.0 International licenseauthor/funder. It is made available under a
The copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.04.06.027573doi: bioRxiv preprint 
Antibodies and Immunoblot Analyses:  
Antibodies used in immunoblotting (IB) assay are CtBP2 antibody (discontinued 
by SCBT; E-16: sc-5966) and GAPDH antibody (SCBT, sc-47724). Antibodies 
were used at dilutions suggested by the manufacturers. For immunoblot analysis, 
25 µg of total protein extract was boiled at 95°C in sample buffer, followed by 
separation on SDS-PAGE (Novex gels, 4-12% Bis-Tris), and then transferred onto 
nitrocellulose membrane (0.45-mm porosity) (GE Healthcare). The membrane 
was incubated for 1 to 2 hours in blocking buffer [Tris-buffered saline, 0.1% 
Tween (TBS-T), 5% nonfat dry milk], followed by incubation overnight at 4°C 
with the primary antibody solubilized in blocking buffer with sodium azide 
(0.01%). After 3X washes of 5 minutes with TBS-T, the blot was incubated with 
Alexa Fluor 680 or 790 nm secondary antibodies (Invitrogen) for 1 hour in TBS-T 
and visualized on a Bio-Rad imager. 
Cell Culture and Transfection 
HCT116; CtBP2(-/-) (Chawla et al., 2018; Dcona et al., 2019) were maintained in 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% (v/v) 
FBS and penicillin–streptomycin in a humidified incubator equilibrated with 5% 
CO2 at 37°C. Cells  were authenticated by examination of morphology and 
growth characteristics and were confirmed to be mycoplasma-free using DAPI-
staining and PCR. Transfections were performed using a standard protocol for 
Lipofectamine-2000 (LP2000) (Thermo-Fisher) based plasmid delivery. Briefly, 
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required concentrations of plasmids and LP2000 were solubilized in 100 µL of 
Opti-MEM media in different tubes. After 10 minutes of incubation at room 
temperature, the contents from tube containing LP2000 were pipetted into the 
tube containing plasmid solution to form a complex. After further incubation of 
30 minutes, the complex was pipetted into the media to transfect HCT116; 
CtBP2(-/-) cells.  
Site-directed Mutagenesis and PCR:  
The CtBP2WT mammalian expression vector expresses full-length CtBP2 in a 
modified pcDNA3.0 mammalian expression vector that also expresses GFP and 
puromycin acetyltransferase (PAC) as a chimeric protein (M. Michael Dcona et 
al., 2019). A QuikChange site-directed mutagenesis protocol was used to generate 
the tetramer-deficient CtBP2 mutants using the CtBP2WT expression vector as a 
template, namely, S128T, A129L, R190Q, G216N and L221Y. 
RT-PCR and real-time RT-PCR 
48 hours post-transfection with 6-8 μg of empty-vector, CtBP2WT, S128T, 
A129L, R190Q, G216N or L221Y plasmids into HCT116; CtBP2(-/-) cells, 
total cellular RNAs were isolated from samples using QIAGEN RNeasy kit and 
instructions therein. Later, cDNA synthesis was carried out using SensiFAST 
cDNA Synthesis Kit from BIOLINE. Quantitation of all gene transcripts was 
done by qPCR using SYBR Green (Applied Biosystems, Foster City, CA) and 
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an ABI 7300 (Applied Biosystems) machine. 18srRNA expression was used as 
an internal control.  
The primer pairs used were:  
18srRNA: 5′-CGCCGCTAGAGGTGAAATTC -3′ (forward) and   
5′- TGGCAAATGCTTTCGCTCTG-3′ (reverse); 
TIAM1: 5′- CGCTGGAGTCGTACCTCATC-3′ (forward) and  
5′-GGTCAAACACAGCCCCAAAC-3′ (reverse) 
Relative amounts of the mRNA transcripts were calculated using the 
ΔΔCT method and reported as fold change with respect to empty-vector 
transfection(Schmittgen & Livak, 2008). The experiments were repeated N=3 
times and the statistical significance was calculated using one-way ANOVA.   
In Vitro Wound-Healing Assay   
HCT116; CtBP2(-/-) cells were seeded into six-well dishes at a density of 5 X 
105 cells/well. The dishes were cultured as confluent monolayers and were then 
transfected with 3 µg of EV, CtBP2WT, S128T, A129L, R190Q, G216N or L221Y 
expression plasmids. 24 hours post-transfection, the equivalent transfection 
efficiency of all plasmids was confirmed by indirect fluorescence microscopy for 
GFP, and a scratch was then made once per well with a 200-µl pipette tip to create 
an artificial wound. Wounded cell cultures were then incubated in the presence of 
DMEM after thorough, but gentle washes. The migration of cells was monitored 
over a duration of 24 hours as a function of how far from the scratch line the cells 
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had progressed. The scratch closures were quantified using ImageJ (NIH) using 
wound-healing macros. The area at a time point is normalized relative to 0-hour 
time and reported as absolute value. The experiments were repeated N=3 times 
and the statistical significance was calculated using one-way ANOVA. 
Acknowledgements:  We are grateful to Dr. Gabriel Demo for his mentorship in 
teaching AMJ single particle cryoEM analysis. His teaching has been invaluable 
to AMJ’s ability to conduct the analysis for this paper. We thank Dr. Anna 
Loveland for valuable discussions and feedback on the manuscript. We thank 
members of the Kelch Lab: Dr. Christl Gaubitz, Dr. Nicholas Stone and Dr. 
Janelle Hayes for insightful discussions on data analysis and sharing resources. 
We thank Drs. Kyounghwan Lee, KangKang, Song and Chen Xu for their help 
with data collection at the UMMS cryoEM Facility. Many thanks to Mr. Florian 
Leidner for setting up our workstation. We thank Dr. Benjamin Morris for 
creating the A129L mutant mammalian expression vector used in the cell-based 
assays.  Services in support of the research project were generated by the VCU 
Massey Cancer Center Biostatistics Shared Resource, supported, in part, with 
funding from NIH-NCI Cancer Center Support Grant P30 CA016059. This work 
is supported by NIH grant R01 GM119014 to WER and NIH grant F31 
GM129988 to AMJ. 
.CC-BY-NC-ND 4.0 International licenseauthor/funder. It is made available under a
The copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.04.06.027573doi: bioRxiv preprint 
References:	
Adams, P. D., Afonine, P. V., Bunkoczi, G., Chen, V. B., Davis, I. W., Echols, N., . . . 
Zwart, P. H. (2010). PHENIX: a comprehensive Python-based system for 
macromolecular structure solution. Acta crystallographica. Section D, Biological 
crystallography, 66(Pt 2), 213-221. doi:10.1107/S0907444909052925

Barroilhet, L., Yang, J., Hasselblatt, K., Paranal, R. M., Ng, S. K., Rauh-Hain, J. A., . . . 
Ng, S. W. (2013). C-terminal binding protein-2 regulates response of epithelial 
ovarian cancer cells to histone deacetylase inhibitors. Oncogene, 32(33), 
3896-3903. doi:10.1038/onc.2012.380

Bellesis, A. G., Jecrois, A. M., Hayes, J. A., Schiffer, C. A., & Royer, W. E., Jr. (2018). 
Assembly of human C-terminal binding protein (CtBP) into tetramers. The 
Journal of biological chemistry, 293(23), 9101-9112. doi:10.1074/
jbc.RA118.002514

Bergman, L. M., & Blaydes, J. P. (2006). C-terminal binding proteins: emerging roles in 
cell survival and tumorigenesis. Apoptosis, 11(6), 879-888. doi:10.1007/
s10495-006-6651-4

Bi, C., Meng, F., Yang, L., Cheng, L., Wang, P., Chen, M., . . . Xie, H. (2018). CtBP 
represses Dpp signaling as a dimer. Biochemical and biophysical research 
communications, 495(2), 1980-1985. doi:10.1016/j.bbrc.2017.12.018

Boyd, J. M., Subramanian, T., Schaeper, U., La Regina, M., Bayley, S., & Chinnadurai, 
G. (1993). A region in the C-terminus of adenovirus 2/5 E1a protein is required 
for association with a cellular phosphoprotein and important for the negative 
modulation of T24-ras mediated transformation, tumorigenesis and metastasis. 
EMBO J, 12(2), 469-478. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/
8440238 
Chawla, A. T., Chougoni, K. K., Joshi, P. J., Cororaton, A. D., Memari, P., Stansfield, J. 
C., . . . Grossman, S. R. (2019). CtBP-a targetable dependency for tumor-
initiating cell activity and metastasis in pancreatic adenocarcinoma. 
Oncogenesis, 8(10), 55. doi:10.1038/s41389-019-0163-x

Chawla, A. T., Cororaton, A. D., Idowu, M. O., Damle, P. K., Szomju, B., Ellis, K. C., . . . 
Grossman, S. R. (2018). An intestinal stem cell niche in Apc mutated neoplasia 
targetable by CtBP inhibition. Oncotarget, 9(65), 32408-32418. doi:10.18632/
oncotarget.25784

Chen, J., Sawyer, N., & Regan, L. (2013). Protein-protein interactions: general trends in 
the relationship between binding affinity and interfacial buried surface area. 
Protein science : a publication of the Protein Society, 22(4), 510-515. doi:
10.1002/pro.2230

Chen, J. E., Huang, C. C., & Ferrin, T. E. (2015). RRDistMaps: a UCSF Chimera tool for 
viewing and comparing protein distance maps. Bioinformatics (Oxford, England), 
31(9), 1484-1486. doi:10.1093/bioinformatics/btu841

Chen, V. B., Arendall, W. B., 3rd, Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, 
G. J., . . . Richardson, D. C. (2010). MolProbity: all-atom structure validation for 
macromolecular crystallography. Acta crystallographica. Section D, Biological 
crystallography, 66(Pt 1), 12-21. doi:10.1107/S0907444909042073

Chinnadurai, G. (2007). Transcriptional regulation by C-terminal binding proteins. Int J 
Biochem Cell Biol, 39(9), 1593-1607. doi:10.1016/j.biocel.2007.01.025

Chinnadurai, G. (2009). The transcriptional corepressor CtBP: a foe of multiple tumor 
suppressors. Cancer Res, 69(3), 731-734. doi:10.1158/0008-5472.CAN-08-3349

Dcona, M. M., Damle, P. K., Zarate-Perez, F., Morris, B. L., Nawaz, Z., Dennis, M. J., . . . 
Grossman, S. R. (2019). Active-Site Tryptophan, the Target of Antineoplastic C-
.CC-BY-NC-ND 4.0 International licenseauthor/funder. It is made available under a
The copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.04.06.027573doi: bioRxiv preprint 
Terminal Binding Protein Inhibitors, Mediates Inhibitor Disruption of CtBP 
Oligomerization and Transcription Coregulatory Activities. Molecular 
pharmacology, 96(1), 99-108. doi:10.1124/mol.118.114363

Dcona, M. M., Morris, B. L., Ellis, K. C., & Grossman, S. R. (2017). CtBP- an emerging 
oncogene and novel small molecule drug target: Advances in the understanding 
of its oncogenic action and identification of therapeutic inhibitors. Cancer Biol 
Ther, 18(6), 379-391. doi:10.1080/15384047.2017.1323586

Deng, H., Liu, J., Deng, Y., Han, G., Shellman, Y. G., Robinson, S. E., . . . Zhang, Q. 
(2013). CtBP1 is expressed in melanoma and represses the transcription of 
p16INK4a and Brca1. J Invest Dermatol, 133(5), 1294-1301. doi:10.1038/jid.
2012.487

Di, L. J., Byun, J. S., Wong, M. M., Wakano, C., Taylor, T., Bilke, S., . . . Gardner, K. 
(2013). Genome-wide profiles of CtBP link metabolism with genome stability and 
epithelial reprogramming in breast cancer. Nat Commun, 4, 1449. doi:10.1038/
ncomms2438

Emsley, P., & Cowtan, K. (2004). Coot: model-building tools for molecular graphics. Acta 
crystallographica. Section D, Biological crystallography, 60(Pt 12 Pt 1), 
2126-2132. doi:10.1107/S0907444904019158

Good, M. C., Zalatan, J. G., & Lim, W. A. (2011). Scaffold proteins: hubs for controlling 
the flow of cellular information. Science (New York, N.Y.), 332(6030), 680-686. 
doi:10.1126/science.1198701

Grant, T., Rohou, A., & Grigorieff, N. (2018). cisTEM, user-friendly software for single-
particle image processing. eLife, 7, e35383. doi:10.7554/eLife.35383

Grigorieff, N. (2016). Frealign: An Exploratory Tool for Single-Particle Cryo-EM. Methods 
in enzymology, 579, 191-226. doi:10.1016/bs.mie.2016.04.013

Grooteclaes, M., Deveraux, Q., Hildebrand, J., Zhang, Q., Goodman, R. H., & Frisch, S. 
M. (2003). C-terminal-binding protein corepresses epithelial and proapoptotic 
gene expression programs. Proc Natl Acad Sci U S A, 100(8), 4568-4573. doi:
10.1073/pnas.0830998100

Hilbert, B. J., Grossman, S. R., Schiffer, C. A., & Royer, W. E., Jr. (2014). Crystal 
structures of human CtBP in complex with substrate MTOB reveal active site 
features useful for inhibitor design. FEBS letters, 588(9), 1743-1748. doi:
10.1016/j.febslet.2014.03.026

Hilbert, B. J., Morris, B. L., Ellis, K. C., Paulsen, J. L., Schiffer, C. A., Grossman, S. R., & 
Royer, W. E., Jr. (2015). Structure-Guided Design of a High Affinity Inhibitor to 
Human CtBP. ACS Chem Biol, 10(4), 1118-1127. doi:10.1021/cb500820b

Hildebrand, J. D., & Soriano, P. (2002). Overlapping and unique roles for C-terminal 
binding protein 1 (CtBP1) and CtBP2 during mouse development. Mol Cell Biol, 
22(15), 5296-5307. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/
12101226 
Kremer, J. R., Mastronarde, D. N., & McIntosh, J. R. (1996). Computer visualization of 
three-dimensional image data using IMOD. Journal of structural biology, 116(1), 
71-76. doi:10.1006/jsbi.1996.0013

Krissinel, E., & Henrick, K. (2007). Inference of macromolecular assemblies from 
crystalline state. J Mol Biol, 372(3), 774-797. doi:10.1016/j.jmb.2007.05.022

Kucukelbir, A., Sigworth, F. J., & Tagare, H. D. (2014). Quantifying the local resolution of 
cryo-EM density maps. Nature methods, 11(1), 63-65. doi:10.1038/nmeth.2727

Kumar, V., Carlson, J. E., Ohgi, K. A., Edwards, T. A., Rose, D. W., Escalante, C. R., . . . 
Aggarwal, A. K. (2002). Transcription corepressor CtBP is an NAD(+)-regulated 
dehydrogenase. Mol Cell, 10 (4), 857-869. Retrieved from http://
www.ncbi.nlm.nih.gov/pubmed/12419229 
.CC-BY-NC-ND 4.0 International licenseauthor/funder. It is made available under a
The copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.04.06.027573doi: bioRxiv preprint 
Kuppuswamy, M., Vijayalingam, S., Zhao, L. J., Zhou, Y., Subramanian, T., Ryerse, J., & 
Chinnadurai, G. (2008). Role of the PLDLS-binding cleft region of CtBP1 in 
recruitment of core and auxiliary components of the corepressor complex. Mol 
Cell Biol, 28(1), 269-281. doi:10.1128/MCB.01077-07

Ma, Y., Sekiya, M., Kainoh, K., Matsuda, T., Iwasaki, H., Osaki, Y., . . . Shimano, H. 
(2020). Transcriptional co-repressor CtBP2 orchestrates epithelial-mesenchymal 
transition through a novel transcriptional holocomplex with OCT1. Biochemical 
and biophysical research communications, 523(2), 354-360. doi:10.1016/j.bbrc.
2019.12.070

Madison, D. L., Wirz, J. A., Siess, D., & Lundblad, J. R. (2013). Nicotinamide adenine 
dinucleotide-induced multimerization of the co-repressor CtBP1 relies on a 
switching tryptophan. The Journal of biological chemistry, 288(39), 
27836-27848. doi:10.1074/jbc.M113.493569

Madison, D. L., Wirz, J. A., Siess, D., & Lundblad, J. R. (2013). Nicotinamide adenine 
dinucleotide-induced multimerization of the co-repressor CtBP1 relies on a 
switching tryptophan. The Journal of biological chemistry, 288(39), 
27836-27848. doi:10.1074/jbc.M113.493569

Mani-Telang, P., Sutrias-Grau, M., Williams, G., & Arnosti, D. N. (2007). Role of NAD 
binding and catalytic residues in the C-terminal binding protein corepressor. 
FEBS letters, 581(27), 5241-5246. doi:10.1016/j.febslet.2007.10.011

Mastronarde, D. N. (2005). Automated electron microscope tomography using robust 
prediction of specimen movements. Journal of structural biology, 152(1), 36-51. 
doi:10.1016/j.jsb.2005.07.007

Nardini, M., Spano, S., Cericola, C., Pesce, A., Massaro, A., Millo, E., . . . Bolognesi, M. 
(2003). CtBP/BARS: a dual-function protein involved in transcription co-
repression and Golgi membrane fission. EMBO J, 22(12), 3122-3130. doi:
10.1093/emboj/cdg283

Nardini, M., Valente, C., Ricagno, S., Luini, A., Corda, D., & Bolognesi, M. (2009). 
CtBP1/BARS Gly172-->Glu mutant structure: impairing NAD(H)-binding and 
dimerization. Biochemical and biophysical research communications, 381(1), 
70-74. doi:10.1016/j.bbrc.2009.02.010

Paliwal, S., Ho, N., Parker, D., & Grossman, S. R. (2012). CtBP2 Promotes Human 
Cancer Cell Migration by Transcriptional Activation of Tiam1. Genes Cancer, 
3(7-8), 481-490. doi:10.1177/1947601912463695

Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. 
C., & Ferrin, T. E. (2004). UCSF Chimera--a visualization system for exploratory 
research and analysis. Journal of computational chemistry, 25(13), 1605-1612. 
doi:10.1002/jcc.20084

Quintyn, R. S., Yan, J., & Wysocki, V. H. (2015). Surface-Induced Dissociation of 
Homotetramers with D2 Symmetry Yields their Assembly Pathways and 
Characterizes the Effect of Ligand Binding. Chemistry & biology, 22(5), 583-592. 
doi:10.1016/j.chembiol.2015.03.019

Schmittgen, T. D., & Livak, K. J. (2008). Analyzing real-time PCR data by the 
comparative C(T) method. Nat Protoc, 3(6), 1101-1108. doi:10.1038/nprot.
2008.73

Shi, Y., Sawada, J., Sui, G., Affar el, B., Whetstine, J. R., Lan, F., . . . Shi, Y. (2003). 
Coordinated histone modifications mediated by a CtBP co-repressor complex. 
Nature, 422(6933), 735-738. doi:10.1038/nature01550

Soutourina, J. (2018). Transcription regulation by the Mediator complex. Nature reviews. 
Molecular cell biology, 19(4), 262-274. doi:10.1038/nrm.2017.115

Sun, L., & Fang, J. (2016). Epigenetic regulation of epithelial-mesenchymal transition. 
Cell Mol Life Sci, 73(23), 4493-4515. doi:10.1007/s00018-016-2303-1

.CC-BY-NC-ND 4.0 International licenseauthor/funder. It is made available under a
The copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.04.06.027573doi: bioRxiv preprint 
Tan, Y. Z., Baldwin, P. R., Davis, J. H., Williamson, J. R., Potter, C. S., Carragher, B., & 
Lyumkis, D. (2017). Addressing preferred specimen orientation in single-particle 
cryo-EM through tilting. Nature methods, 14(8), 793-796. doi:10.1038/nmeth.
4347

Thio, S. S., Bonventre, J. V., & Hsu, S. I. (2004). The CtBP2 co-repressor is regulated by 
NADH-dependent dimerization and possesses a novel N-terminal repression 
domain. Nucleic Acids Res, 32(5), 1836-1847. doi:10.1093/nar/gkh344

Turner, J., & Crossley, M. (2001). The CtBP family: enigmatic and enzymatic 
transcriptional co-repressors. BioEssays : news and reviews in molecular, cellular 
and developmental biology, 23(8), 683-690. doi:10.1002/bies.1097

Vilar, J. M. G., & Saiz, L. (2005). DNA looping in gene regulation: from the assembly of 
macromolecular complexes to the control of transcriptional noise. Current 
opinion in genetics & development, 15(2), 136-144. doi:10.1016/j.gde.
2005.02.005

Villar, G., Wilber, A. W., Williamson, A. J., Thiara, P., Doye, J. P. K., Louis, A. A., . . . Levy, 
E. D. (2009). Self-assembly and evolution of homomeric protein complexes. 
Physical review letters, 102(11), 118106-118106. doi:10.1103/PhysRevLett.
102.118106

Wang, R., Asangani, I. A., Chakravarthi, B. V., Ateeq, B., Lonigro, R. J., Cao, Q., . . . 
Varambally, S. (2012). Role of transcriptional corepressor CtBP1 in prostate 
cancer progression. Neoplasia, 14(10), 905-914. Retrieved from http://
www.ncbi.nlm.nih.gov/pubmed/23097625 
Zhang, Q., Piston, D. W., & Goodman, R. H. (2002). Regulation of corepressor function 
by nuclear NADH. Science (New York, N.Y.), 295(5561), 1895-1897. doi:10.1126/
science.1069300

Zheng, X., Song, T., Dou, C., Jia, Y., & Liu, Q. (2015). CtBP2 is an independent 
prognostic marker that promotes GLI1 induced epithelial-mesenchymal 
transition in hepatocellular carcinoma. Oncotarget, 6(6), 3752-3769. doi:
10.18632/oncotarget.2915

Zivanov, J., Nakane, T., Forsberg, B. O., Kimanius, D., Hagen, W. J., Lindahl, E., & 
Scheres, S. H. (2018). New tools for automated high-resolution cryo-EM 
structure determination in RELION-3. eLife, 7, e42166. doi:10.7554/eLife.42166

.CC-BY-NC-ND 4.0 International licenseauthor/funder. It is made available under a
The copyright holder for this preprint (which was not peer-reviewed) is the. https://doi.org/10.1101/2020.04.06.027573doi: bioRxiv preprint 
A
B
Figure 1. Overall structure of CtBP231-364. (A) Refined and B-factor sharpened 3d reconstruction of 
CtBP33-364  with tetrameric architecture. (B) Local resolution of final map. (C.) Cartoon representation of 
the EM model with four NADH molecules. Chains A and C are in green cyan, chains B and D are in light 
blue. 
Figure supplement 1A-E: CryoEM pipeline of CtBP231-364 
Figure supplement 2A-C: FSC of final reconstruction. Angular distribution of refined particles.
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Figure 2. Overall structure of CtBP231-445. (A) Refined and B-factor sharpened 3d reconstruction of 
CtBP31-445 with tetrameric architecture. (B) Fitting of CtBP231-364  EM model into the the CtBP231-445 EM 
reconstruction.. Both the construct with the truncated dehydrogenase domain and the longer construct form 
stable tetramers. (C) CtBP231-364  map low-pass filtered to 10Å..Diffmap	analysis.	density	(magenta)	from	
CtBP231-445		mapped	onto	the	low-pass	@iltered	map	of	CtBP31-364  
Figure Supplement 3: CryoEM pipeline of CtBP231-445 
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EM 
Figure 3. Comparison of the EM and crystal Structures of 
CtBP231-364. (A) Side by side comparison of the EM model 
and crystal structures of CtBP231-364. (B) Structural comparison 
by superimposing amino acids 31-364 of the cryoEM and 
crystal structures. (C) The NADH molecules of both models 
align perfectly (D) The interdimer loop with the Leu221 
residues superimposes really well onto each other depicting the 
stability of that region during tetramer assembly. (E) Most of 
the differences between the two structures lie in the co-factor 
binding domain. The RMSD between the two structures is 
0.781Å.  
Figure Supplement6: Cα-Cα distance map analysis  of 
cryoEM and Crystallography structures.
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Figure 4. Hydrophilic and hydrophobic interactions that stabilize the tetramer interface. (A) 
Representative view of CtBP231-364 and the amino acids (B) Zoomed in view of the interactions 
between NADH (yellow), Arg190 (violet) and Asp215 (marine) across the tetramer interface. (C) 
Hydrophobic packing of Leu221 stabilizing the tetramer. (D) Representative view of key residues 
(Ser128, Ala129, GLy216)  of the hinge region between the substrate and co-factor binding domains. 
Figure Supplement 7: Representative density of one dimer interface and interactions. 
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Figure 5. Dimer stabilization. (A) Cartoon 
representation of the dimer between chain A (light 
blue) and chain B (greencyan) with two NADH 
(yellow). (B) For clarity only the dimer interface 
between the two chains, for clarity only the dimeric 
interface is shown in green cyan and light blue. (C) 
Hydrogen-bonding network at the intradimer 
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Figure 6. Tetramerization of CtBP2 is critical for co-transcriptional activity. HCT116 
CtBP2(-/-) cells were transfected with either plasmids encoding either WT CtBP2WT or 
tetramer destabilizing mutants (S128T, A129L, R190Q, G216N and L221Y). (A) RT-qPCR 
analysis of TIAM1 gene expression. Fold change of expression was normalized to 18sRNA. (B) 
Quantification of area of migration after scratch assay. All assays were repeated N=3 times, and 
statistical significance was calculated using one-way ANOVA, where * indicates p < 0. 05; ** p   
< 0.01; *** p  <  0.001.Asterisks indicate significant difference between the different variants.  
Figure Supplement 8: Expression level of CtBP2 variants.  
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Voltage (kV) 200 300
Nominal Magnification 45000 105000
Detector K3 Summit K3 Summit
Pixel size (Å) (calibrated at the detector) 0.435 0.415
Pixel size (Å) of binned and aligned movies 0.87 0.83
Exposure Time (s) 1.7 1.5
Electron Exposure (e/Å2) 37 40.5
Defocus range (𝜇m) -1.5 to -3 -1.5 to -3
Number of Micrographs 3405 3405
Reconstruction
Software cisTEM, Relion 3.0 cisTEM, Relion 3.0
# of particles picked 485,473 671,078
# of particle post 2D-classificattion 173,723 671,078
Final Refined Particles 112,919 46,426
Symmetry imposed D2 D2
Resolution Å (FSC 0.143) 3.6 6-10
Applied B-factor (Å2) -207 -37
Refinement
Protein Residues 31-345
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Table 2: PISA Analysis of CtBP231-364  CryoEM Structure. 












AB 2922 -41.2 36.5 17 31 -
CD 3013 -40.6 32.1 15 39 -
AD 876 - - - 9 4
CB 841 - - - 13 7
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3D classification (D2)  - RELION 
Ab initio (C1) - cisTEM 
173,723 particles 
3D refinement_ (D2)  - RELION 
Mask (3.9Å)
33007 particles  
13.9Å
112919 particles  
7.4 Å
26058 particles  
11.1Å
Figure Supplement 1F
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Figure	Supplement	4-	Orthogonal	slices	of	the		ab	initio	reconstruction		of	CtBP231-364	
Figure Supplement 4
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